 Immunity cyclosporine therapy Cyclosporine cytotoxic production immunologic memory-building growth factors inhibitory effects effector phase certain immune reactions inhibitory effects reversible treatment immune competence cyclosporine-treated patients returns normal contrast conventional cytotoxic immunosuppressive agents lymphocyte clones therapy clonal deletions permanent loss immunologic memory antigens lymphocytes adults involuted thymus transplant patients cyclosporine combination various immunosuppressive agents reports combination drug conventional immunosuppressive agents early appearance non-Hodgkin lymphoma endocrine-related tumors increase cancers patients cyclosporine conditions psoriasis autoimmune diseases Treatment adults cytotoxic immunosuppressive drugs T-lymphocyte clones control latent oncogenic viruses certain malignant cells patients cyclosporine suppression T-cell function impairment cytokine-mediated stimulation natural killer cells cytotoxic macrophages tumor growth cyclosporine monotherapy increased incidence tumors psoriasis patients cyclosporine PUVA methotrexate therapy comparison cancer incidence different categories patients issue